Topical NSAIDs Should NOT Be Used for Viral Conjunctivitis
Topical NSAIDs are not recommended for the treatment of viral conjunctivitis. The 2024 American Academy of Ophthalmology Conjunctivitis Preferred Practice Pattern guidelines make no mention of topical NSAIDs as a treatment option for any form of viral conjunctivitis, including adenoviral, HSV, or VZV conjunctivitis 1.
Why NSAIDs Are Not Recommended
The guideline evidence is clear in its omission—when discussing management of viral conjunctivitis, the focus is on:
- Supportive care (cold compresses, artificial tears)
- Topical corticosteroids (only for severe cases with membranous conjunctivitis, marked chemosis, or symptomatic subepithelial infiltrates)
- Topical/oral antivirals (specifically for HSV and VZV, not adenovirus)
- Antiseptics like povidone-iodine (under investigation for adenoviral conjunctivitis)
NSAIDs are conspicuously absent from these treatment algorithms 1.
What the Research Shows
While one older study from 1997 suggested piroxicam eye drops might accelerate recovery in acute hemorrhagic conjunctivitis 2, this finding has not been incorporated into current clinical guidelines. More importantly:
- A 1998 study demonstrated that topical NSAIDs (ketorolac and diclofenac) showed no significant antiviral activity against common adenoviral serotypes in vitro or in animal models 3
- A 2022 survey of Turkish ophthalmologists found only 19.6% used topical NSAIDs for adenoviral conjunctivitis, indicating limited real-world adoption 4
- NSAIDs carry risks of corneal complications, including epithelial toxicity and corneal melts, particularly when used with other agents or in compromised corneas 5
The Correct Treatment Approach
For Adenoviral Conjunctivitis (Most Common):
- Mild cases: Supportive care only—cold compresses and preservative-free artificial tears
- Severe cases (membranous conjunctivitis, marked chemosis, epithelial sloughing): Consider topical corticosteroids (loteprednol or fluorometholone preferred) with close IOP monitoring 1
- Subepithelial infiltrates causing vision symptoms: Low-dose topical corticosteroids or cyclosporine 0.05-1% 1
For HSV Conjunctivitis:
- Topical ganciclovir 0.15% gel 3-5 times daily OR trifluridine 1% solution 5-8 times daily
- Oral antivirals (acyclovir, valacyclovir, or famciclovir)
- Avoid topical corticosteroids as they potentiate HSV epithelial infections 1
For VZV Conjunctivitis:
- Oral antivirals (acyclovir 800mg 5x daily, valacyclovir 1000mg q8h, or famciclovir 500mg TID for 7 days)
- Topical antibiotics to prevent secondary bacterial infection 1
Critical Pitfall to Avoid
Do not confuse topical NSAIDs with topical corticosteroids. While corticosteroids have a defined (albeit limited) role in severe viral conjunctivitis, NSAIDs do not. The evidence shows NSAIDs lack antiviral efficacy and provide no clear benefit over supportive care, while carrying their own risks of ocular surface toxicity 3, 5.